← Eichor
Study identifier: NCT07024992 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Enhancing Smoking Cessation for African American People Everywhere

Condition: ESCAPE Intervention+NRT · quitSTART Intervention+NRT · CTRL+NRT  ·  Sponsor: University of Houston

PhasePhase 2
Planned participants300
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The present study aims to investigate the efficacy of an mHealth smoking cessation and HIV disease management intervention among a nationally representative sample of African America/Black (hereafter refer to as Black) persons with HIV/AIDS (PWH) who smoke cigarettes. Participants will be randomized into one of three conditions: (1) the intervention, ESCAPE (Enhancing Smoking Cessation for African American People Everywhere) + Nicotine Replacement Medications (NRT), (2) the National Cancer Institute's (NCI) quitSTART app, the standard mobile smoking cessation treatment + NRT, and (3) an assessment-only control group + NRT.

This description comes directly from the study's public registry record.

Talk to the study team

Lorra Garey, Ph.D.  ·  713-743-8056  ·  llgarey@central.uh.edu

Katie Pereira, M.S.  ·  713-743-9567  ·  kmpereira@central.uh.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of Oklahoma Health Sciences CenterOklahoma City, Oklahoma, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07024992